Variantes de progranulina
Se proporcionan en la presente variantes de progranulina y proteínas de fusión que comprenden una variante de progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo,...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PROROK, Rachel SRIVASTAVA, Ankita KANNAN, Gunasekaran LOW, Ray L.Y CHERF, Gerald Maxwell LEXA, Katrina W |
| description | Se proporcionan en la presente variantes de progranulina y proteínas de fusión que comprenden una variante de progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)).
Provided herein are progranulin variants and fusion proteins that comprise a progranulin variant and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2022001712A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2022001712A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2022001712A13</originalsourceid><addsrcrecordid>eNrjZJAMSyzKTMwrSS1WSElVKCjKTy9KzCvNycxL5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8c4-RgZGRgYGhuaGRo6GxsSpAgCvkyNs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Variantes de progranulina</title><source>esp@cenet</source><creator>PROROK, Rachel ; SRIVASTAVA, Ankita ; KANNAN, Gunasekaran ; LOW, Ray L.Y ; CHERF, Gerald Maxwell ; LEXA, Katrina W</creator><creatorcontrib>PROROK, Rachel ; SRIVASTAVA, Ankita ; KANNAN, Gunasekaran ; LOW, Ray L.Y ; CHERF, Gerald Maxwell ; LEXA, Katrina W</creatorcontrib><description>Se proporcionan en la presente variantes de progranulina y proteínas de fusión que comprenden una variante de progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)).
Provided herein are progranulin variants and fusion proteins that comprise a progranulin variant and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230324&DB=EPODOC&CC=CL&NR=2022001712A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230324&DB=EPODOC&CC=CL&NR=2022001712A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PROROK, Rachel</creatorcontrib><creatorcontrib>SRIVASTAVA, Ankita</creatorcontrib><creatorcontrib>KANNAN, Gunasekaran</creatorcontrib><creatorcontrib>LOW, Ray L.Y</creatorcontrib><creatorcontrib>CHERF, Gerald Maxwell</creatorcontrib><creatorcontrib>LEXA, Katrina W</creatorcontrib><title>Variantes de progranulina</title><description>Se proporcionan en la presente variantes de progranulina y proteínas de fusión que comprenden una variante de progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)).
Provided herein are progranulin variants and fusion proteins that comprise a progranulin variant and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAMSyzKTMwrSS1WSElVKCjKTy9KzCvNycxL5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8c4-RgZGRgYGhuaGRo6GxsSpAgCvkyNs</recordid><startdate>20230324</startdate><enddate>20230324</enddate><creator>PROROK, Rachel</creator><creator>SRIVASTAVA, Ankita</creator><creator>KANNAN, Gunasekaran</creator><creator>LOW, Ray L.Y</creator><creator>CHERF, Gerald Maxwell</creator><creator>LEXA, Katrina W</creator><scope>EVB</scope></search><sort><creationdate>20230324</creationdate><title>Variantes de progranulina</title><author>PROROK, Rachel ; SRIVASTAVA, Ankita ; KANNAN, Gunasekaran ; LOW, Ray L.Y ; CHERF, Gerald Maxwell ; LEXA, Katrina W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2022001712A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PROROK, Rachel</creatorcontrib><creatorcontrib>SRIVASTAVA, Ankita</creatorcontrib><creatorcontrib>KANNAN, Gunasekaran</creatorcontrib><creatorcontrib>LOW, Ray L.Y</creatorcontrib><creatorcontrib>CHERF, Gerald Maxwell</creatorcontrib><creatorcontrib>LEXA, Katrina W</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PROROK, Rachel</au><au>SRIVASTAVA, Ankita</au><au>KANNAN, Gunasekaran</au><au>LOW, Ray L.Y</au><au>CHERF, Gerald Maxwell</au><au>LEXA, Katrina W</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Variantes de progranulina</title><date>2023-03-24</date><risdate>2023</risdate><abstract>Se proporcionan en la presente variantes de progranulina y proteínas de fusión que comprenden una variante de progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)).
Provided herein are progranulin variants and fusion proteins that comprise a progranulin variant and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CL2022001712A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Variantes de progranulina |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T02%3A45%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PROROK,%20Rachel&rft.date=2023-03-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2022001712A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |